The notification of the United Kingdom (“UK”) regarding the withdrawal from the European Union (“Brexit”) will affect manufacturers of medical devices which are in possession of certificates issued by a notified body located in the UK or which have authorised representatives located in the UK. These companies need to anticipate the regulatory steps that will be carried out as a consequence of Brexit so that they can continue to operate and supply the EU market.
We can advise and assist manufacturers of medical devices with all the steps necessary to conform with current and future EU legislation. With our broad international network and experience, we can ensure that the abovementioned transfers of certificates and authorised representative are fully completed and implemented before 30 March 2019 so that the manufacturer can continue to operate and supply the EU market after Brexit.
Read more >>